Yatsen Hldg Ltd Stock Price, News & Analysis

Yatsen Holding Limited (NYSE: YSG), a leading Chinese beauty group, has scheduled the release of its first quarter 2025 unaudited financial results for Friday, May 16, 2025, before U.S. markets open. The company will host a conference call at 7:30 A.M. U.S. Eastern Time (7:30 P.M. Beijing/Hong Kong Time) on the same day to discuss the results. The call will be accessible via multiple toll-free and international dial-in numbers, with a webcast available on the company's investor relations website. A replay of the call will be available until May 23, 2025.

Yatsen Holding (NYSE: YSG) CEO David Huang shared insights on the company's evolution from a trend-focused startup to a global beauty innovation leader. The company, founded in 2016, has expanded to 11 brands across mass, masstige, and premium segments, including notable acquisitions like Galenic and EVE LOM.

Key highlights include a strategic shift towards science-backed beauty, with over $80 million invested in R&D, 240+ patent filings, and publications in prestigious journals. The company allocates 3% of revenue to R&D, positioning itself among global leaders in beauty innovation spending. Yatsen has successfully resumed profitable growth following its transformation, completed a $200 million share buyback, and maintains a strong domestic supply chain to minimize global trade disruptions.

Operating in China's RMB 400 billion beauty market, Yatsen focuses on high-value, science-driven products like the Biolip Essence Lipstick, while exploring new frontiers in neuroscience applications for skincare.

Yatsen Holding (NYSE: YSG), a leading China-based beauty group, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024. The report was submitted to the U.S. Securities and Exchange Commission (SEC) on April 22, 2025.

The annual report can be accessed through the company's investor relations website at ir.yatsenglobal.com and the SEC's website. Shareholders and ADS holders can request free hard copies of the report by contacting the Investor Relations Department at the company's Guangzhou headquarters.

Yatsen Holding (NYSE: YSG) announced its Q4 and full year 2024 financial results, showing mixed performance. Q4 total net revenues increased by 7.1% to RMB1.15 billion (US$157.3 million), while full year revenues slightly decreased by 0.6% to RMB3.39 billion (US$464.9 million).

The company achieved significant improvements in profitability metrics. Q4 gross margin increased to 77.8% from 73.7% year-over-year, and full year gross margin rose to 77.1% from 73.6%. Q4 delivered a non-GAAP net income of RMB107.0 million (US$14.7 million), compared to a non-GAAP net loss in the prior year period.

Despite these improvements, Yatsen recorded a Q4 net loss of RMB378.8 million (US$51.9 million), primarily due to a RMB403.1 million goodwill impairment related to Eve Lom. For Q1 2025, the company expects total net revenues between RMB788.8 million and RMB866.2 million, representing a year-over-year increase of approximately 2% to 12%.

Yatsen Holding (NYSE: YSG), a leading China-based beauty group, has scheduled the release of its unaudited financial results for the fourth quarter and full year ended December 31, 2024. The results will be announced on Tuesday, February 25, 2025, before U.S. markets open.

The company will host a conference call at 7:30 A.M. U.S. Eastern Time (8:30 P.M. Beijing/Hong Kong Time) on the same day to discuss the financial results. The call will be accessible via various toll-free and international numbers, with a webcast available on the company's investor relations website. A replay of the call will be available until March 4, 2025.

Yatsen Holding (NYSE: YSG) reported Q3 2024 financial results showing total net revenues decreased by 5.7% to RMB677.0 million (US$96.5 million). Despite industry challenges, Skincare Brands revenue increased by 3.6% to RMB267.9 million. Gross margin improved to 75.9% from 71.4% year-over-year. The company reported a net loss of RMB121.1 million, narrowed from RMB197.9 million in the prior year period. For Q4 2024, Yatsen expects total net revenues between RMB1.07 billion and RMB1.18 billion, representing a year-over-year increase of 0% to 10%.

Yatsen Holding (NYSE: YSG), a leading China-based beauty group, has scheduled the release of its unaudited financial results for the third quarter of 2024 on Wednesday, November 20, 2024, before U.S. markets open. The company will host a conference call at 7:30 A.M. U.S. Eastern Time on the same day to discuss the results. An archived webcast will be available on the company's investor relations website, and a conference call replay will be accessible until November 27, 2024.

Yatsen Holding , a leading Chinese beauty group, has published its 2023 Environmental, Social and Governance (ESG) Report. The company retained its MSCI ESG Rating of A for the second consecutive year, outperforming industry averages in key areas such as product packaging, waste management, product carbon footprint, and chemical safety.

Highlights of Yatsen's ESG achievements include:

• Highest-rated company in the Chinese beauty industry by MSCI
• R&D investment reached 3.3% of total net revenues
• Established a cutting-edge beauty factory and three independent R&D centers
• Introduced numerous technological innovations as part of 'Yatsen's Road of Science and Technology'

CEO Jinfeng Huang emphasized the company's commitment to green practices, R&D, and innovation while prioritizing business growth and commercial integrity for a sustainable future.

Yatsen Holding (NYSE: YSG), a leading China-based beauty group, reported its Q2 2024 financial results. Total net revenues decreased by 7.5% to RMB794.5 million (US$109.3 million). Skincare Brands' revenues remained flat at RMB325.2 million (US$44.8 million), accounting for 40.9% of total net revenues. Gross margin improved to 76.7% from 74.7% in the prior year period. Net loss decreased by 21.2% to RMB85.5 million (US$11.8 million). The company faced challenges due to subdued beauty industry performance in China. Despite this, Yatsen's three major clinical and premium skincare brands achieved combined net revenue growth. For Q3 2024, the company expects total net revenues between RMB646.3 million and RMB718.1 million, representing a year-over-year decrease of 0% to 10%.